GO
Loading...

Forest Laboratories Inc

More

  • Early movers: KO, FRX, WM, MDT, NFLX, TSLA & more Tuesday, 18 Feb 2014 | 8:08 AM ET

    Some of the names on the move ahead of the open.

  • Actavis to acquire Forest Labs     Tuesday, 18 Feb 2014 | 7:00 AM ET

    Actavis will acquire Forest Labs for $25 billion in a cash and stock deal.

  • Feb 18- Actavis Plc is in advanced talks to acquire rival drug maker Forest Laboratories Inc in a deal that could value Forest at up to $25 billion, the Wall Street Journal reported citing people familiar with the matter. Actavis competes with larger drugmakers such as Teva Pharmaceuticals Industries Ltd and Mylan Inc..

  • Feb 17- Actavis Plc is in advanced talks to acquire rival drug maker Forest Laboratories Inc in a deal that could value Forest at up to $25 billion, the Wall Street Journal reported citing people familiar with the matter. The deal is expected to be announced as early as Tuesday, but it is possible that the talks could still fall apart, the Journal said.

  • Feb 12- Ventrus Biosciences Inc's shares plunged 66 percent after the company said its lead experimental treatment for anal fissures failed to reduce pain compared with a placebo in a second late-stage trial. The treatment could compete with Rectiv, marketed by Aptalis Pharmaceuticals Inc. Forest Laboratories Inc said in January it would buy Aptalis.

  • *Dow Chemical jumps on Third Point stake. *Verizon, Travelers, JNJ fall after results.

  • Jan 21- Forest Laboratories Inc on Tuesday beat analyst expectations for both profit and revenue and raised its full-year profit forecast, giving investors confidence in new Chief Executive Brent Saunders a year ahead of Forest's key drug coming off patent.

  • *Verizon, Travelers, JNJ climb in premarket after results. *Fellow Dow components Verizon Communications Inc gained 0.9 percent to $48.77 and Johnson& Johnson rose 0.6 percent to $95.61 after posting earnings.

  • Jan 21- Forest Laboratories Inc's results handily beat analysts' estimates in the first full quarter under new Chief Executive Brent Saunders, and the company raised its full-year profit forecast. Forest raised its adjusted earnings forecast to $1.25 to $1.35 per share for its fiscal year ending March 31, from the 95 cents to $1.15 it estimated in October.

  • Early movers: VZ, JNJ, TRV, FRX, HAL, JPM & more Tuesday, 21 Jan 2014 | 8:05 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Forest Labs posts profit, raises full-year forecast Tuesday, 21 Jan 2014 | 7:17 AM ET

    Jan 21- Forest Laboratories Inc posted a profit in the first full quarter under new Chief Executive Brent Saunders, helped by higher sales of its Alzheimer's disease and hypertension drugs. Forest said it expects adjusted earnings for its fiscal year ending March 31 in the range of $1.25 to $1.35 per share.

  • BUDAPEST, Jan 14- Hungarian drugmaker Richter has dismissed as "entirely unrealistic" market speculation that U.S. peer Forest Laboratories Inc might consider it as a potential takeover target. The two companies are linked through a planned new antipsychotic drug, Cariprazine, discovered by Richter and licensed to Forest in the United States and Canada.

  • Forest Labs loses two patents but not lead     Monday, 13 Jan 2014 | 8:20 AM ET

    Brent Saunders, president and CEO at Forest Labs, explains how his company is taking the pharma world by storm and weighs in on several new products in the pipeline.

  • *Forest Labs shares rise; will buy peer Aptalis. NEW YORK, Jan 8- The Dow and the S&P 500 declined modestly on Wednesday as investors awaited the release of minutes from the Federal Reserve's most recent policy meeting, while Micron's strong results helped boost the Nasdaq.

  • *Forest Labs shares rise; will buy peer Aptalis. NEW YORK, Jan 8- U.S. stocks were little changed on Wednesday as investors awaited the release of minutes from the Federal Reserve's most recent policy meeting, while strong results from Micron helped boost the Nasdaq.

  • *Forest Labs shares rise; will buy peer Aptalis. Most Dow components were trading lower, with declines in IBM, Procter& Gamble and McDonald's weighing the most on the price-weighted index. "ADP's number is consistent with other labor numbers we have gotten," said Guy Berger, U.S. economist at RBS Securities in Stamford, Connecticut.

  • *Forest Labs shares rise; will buy peer Aptalis. NEW YORK, Jan 8- U.S. stocks were set to open little changed on Wednesday, a day after the S&P 500 posted its largest gain in three weeks and after a report showed private sector payrolls rose the most in 13 months.

  • Early movers: JPM, TWTR, MCD, F & more Wednesday, 8 Jan 2014 | 7:57 AM ET

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures dip ahead of jobs data, Fed minutes Wednesday, 8 Jan 2014 | 7:50 AM ET

    *Forest Labs to buy Aptalis, shares rise. NEW YORK, Jan 8- U.S. stock index futures fell on Wednesday, a day after the S&P 500 posted its largest gain in three weeks and ahead of jobs data from the private sector. *Micron Technology shares jumped 9 percent in premarket trading a day after it reported a much higher-than-expected quarterly profit.

  • Forest Labs to buy private peer Aptalis for $2.9 bln Wednesday, 8 Jan 2014 | 7:43 AM ET

    Jan 8- Forest Laboratories Inc said it would buy privately held specialty pharmaceutical company Aptalis for about $2.9 billion to gain access to Aptalis's gastrointestinal and lung drugs.

Most Popular Video

Wednesday, 23 Apr 2014 | 12:32 AM ET

Eddie Tam, CIO at Central Asset Investments, says China will see a slowdown for a long time as a trade-off for avoiding a hard landing in its economy.

Tuesday, 22 Apr 2014 | 10:48 PM ET

Todd Elmer, Currency Strategist at Citi, discusses whether the currency's sharp drop following weaker-than-expected quarterly inflation data was justified.

Tuesday, 22 Apr 2014 | 10:30 PM ET

Adaire Fox-Martin, COO, Asia Pacific Japan at SAP, elaborates on the firm's "stunning results" in Southeast Asia, India and the sector of cloud computing in the first-quarter.